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Introduction {#sec005}
============

Severe fever with thrombocytopenia syndrome (SFTS) is a notifiable infectious disease characterized by fever, weakness, leukopenia, thrombocytopenia, gastrointestinal symptoms, and central nervous system manifestations \[[@pone.0175592.ref001]--[@pone.0175592.ref003]\]. The causative agent of SFTS is a novel member of the Phlebovirus in the family Bunyaviridae, SFTS virus (SFTSV), which was first isolated from human beings in rural areas of central China by Yu et al in 2009 \[[@pone.0175592.ref001]\]. About the latter, the disease was also reported in Korea and Japan in 2012, and a disease similar to SFTS has been reported in the United States \[[@pone.0175592.ref004], [@pone.0175592.ref005]\]. More recently, human cases have been widely covered in at least 16 provinces in east and center of China, including Shandong, Zhejiang, Jiangsu, Anhui, Henan, Hubei, and Liaoning provinces, etc \[[@pone.0175592.ref006]\]. The incidence of the disease is very high in some epidemic areas with a case-fatality rate of up to 30%, which has posed an increasingly threat to global health \[[@pone.0175592.ref002]\].

Time range from March to November is the epidemic season of SFTS, May-July is the peak time of SFTSV infection. SFTSV is most likely to be transmitted by tick bite according to evidence from tick exposure history and SFTSV detection in ticks such as Haemaphysalis longicornis ticks, and virus gene sequence analysis showed the virus in ticks closely related to those circulating in humans \[[@pone.0175592.ref007]--[@pone.0175592.ref010]\]. High seroprevalence to SFTSV has been reported in domestic animals such as goats, sheep, cattle, dogs, etc and small mammals such as rodent and shrews. However, the host range of the virus and the role of these animals in the transmission of SFTSV is poorly understood. \[[@pone.0175592.ref011], [@pone.0175592.ref012]\]. In addition, person to person transmission by contacting with infected patient's blood or mucous has been reported in China \[[@pone.0175592.ref013]--[@pone.0175592.ref015]\].

In past years, seroprevalence of SFTSV among healthy population has been widely investigated in various epidemiologic studies. Current estimates of the seroprevalence of SFTSV among general humans in China are almost based on one or several villages with relatively small sample size in one province rather than nationally representative sample of this population. In addition, seroprevalence of SFTSV among healthy humans in different gender, age groups, and endemic regions has yet to be illuminated. Meta-analysis is an effective method of pooling data of individual study together, thus enhancing the statistical power of the analysis for the estimates, to reach a more comprehensive result. It has been widely utilized in sero-epidemiological studies of infectious diseases, such as *Influenza A (H9N2)*, *Ebola and Marburg viruses*, and *Enterovirus 71*, etc \[[@pone.0175592.ref016]--[@pone.0175592.ref018]\]. In present study, we determine the overall pooled seroprevalence of SFTSV among healthy individuals in China by mean of a meta-analysis. We also estimate the pooled seroprevalence of total antibodies to SFTSV in different subgroups of healthy humans.

Materials and methods {#sec006}
=====================

Search strategy {#sec007}
---------------

All relevant articles about the seroprevalence of SFTSV in general population were searched via the following electronic databases: Pubmed, Web of Science, Embase, Chinese National Knowledge Infrastructure (CNKI), Chinese WanFang Database. Date searches were carried out up to November 2016, without restrictions regarding language, publication year and district. The following search words and terms in English and Chinese were used in the final search: ("seroprevalence" or "prevalence" or "serum" or "antibodies" or "seroepidemiology") and ("SFTS" or "SFTSV" or "Severe fever with thrombocytopenia syndrome" or "Severe fever with thrombocytopenia syndrome virus"). Moreover, all relevant references cited in original articles and reviews were also manually searched to identify additional articles not indexed by these databases.

Eligibility criteria {#sec008}
--------------------

To obtain the valid articles we needed, the following criteria were established: 1) the study either reported the seroprevalence of SFTSV or had sufficient data for calculating the seroprevalence; 2) individuals neither had SFTS infection in the past, being hospitalized for any clinically similar disease, or contact with a person who had SFTS as defined previously \[[@pone.0175592.ref001]\]; 3) specific-SFTSV antibody or total antibodies (IgG and IgM) to SFTSV were tested by using a double-antigen sandwich enzyme-linked immune sorbent assay (ELISA) kit or indirect-ELISA. Exclusion criteria included abstracts, conferences, case reports, letters, duplicated publications and studies reporting on SFTSV among population with non-Chinese.

Data extraction {#sec009}
---------------

After initial evaluation, two authors independently and carefully screened the articles on title and abstract according to the eligibility criteria. Authors also filled out a standard quality assessment checklist with 11 items concerning the methodological aspects of cross-sectional studies for each study \[[@pone.0175592.ref019]\]. If the studies were based on the same sample, only the study with greatest epidemiological quality was selected. The following information was extracted from every eligible article: first author, publication year, researched province, sampling time, sampling method, sample size, positive rate in each study, number of research spot and antibodies testing method. We also extracted the number of positive for SFTSV antibodies according to gender, age, occupation and province, in order to estimate the seroprevalence of SFTSV in subgroups. Data with discrepancies in identification were resolved through discussing, if there is no agreement, the third investigator would make an ultimate decision.

Quality assessment {#sec010}
------------------

The quality of the included studies was assessed by Agency for Healthcare Research and Quality (AHRQ), which is consisted of 11-item with a yes/no/unclear response option: "No" or "unclear" was scored "0" and the "Yes" would be scored "1"\[[@pone.0175592.ref019]\]. Articles scored as 0--3, 4--7, 8--11 indicated low, moderate and high quality, respectively.

Statistical analysis {#sec011}
--------------------

According to the results of heterogeneity test in different groups, the proper model was adopted to assess a pooled value and 95%CI of seroprevalence of SFTSV antibodies in healthy population.

Statistical heterogeneity across different studies was assessed by using the Cochran Q and I^2^ statistics \[[@pone.0175592.ref020]\]. *P*-values of the Cochran Q test less than 0.1 is considered to be statistically significant, and I^2^ value more than 75% indicates high heterogeneity. A significant Q statistic (*P*-values\<0.10) indicate heterogeneity across studies, and then the DerSimonian and Laird method in random effect model result is used for meta-analysis. When the *P*-value of heterogeneity test is more than 0.1 (*P*-values\>0.10), the results of Mante-Haenszel method in a fixed-effect model will be adopt. In order to explore the potential source of heterogeneity between studies and the seroprevalences of SFTSV antibodies with different characters such as gender, age, occupation and province, subgroups analysis were also conducted. Additionally, a leave-one-out sensitivity analysis was carried out to assess the impact of each study on the overall pooled estimate.

The potential publication bias was assessed by using Begg's funnel plot \[[@pone.0175592.ref021]\]. Funnel plot asymmetry was further assessed by the method of Egger's linear regression test. If the *P*-value of Egger's test was less than 0.05, statistically significant publication bias might exist.

All statistical analysis were performed using STATA 11.0 (Stata Corporation, College Station, Texas, USA).

Results {#sec012}
=======

Search results {#sec013}
--------------

The detailed study retrieval steps according to the PRISMA statement was shown in [Fig 1](#pone.0175592.g001){ref-type="fig"}. Initially, the search retrieved 669 relevant articles from the Pubmed, Web of Science, Embase, Chinese National Knowledge Infrastructure (CNKI), Chinese WanFang Database. Based on the eligibility criteria, we firstly removed 146 articles due to duplicate publications, and an additional 471 articles were excluded after review of the title and abstract for irrelevant topics or because they were abstracts/letters/reviews/comments/case reports. After carefully reviewing the full text and data of the remaining 52 articles, 31 ineligible records were excluded due to overlapping data or lack of some indicators. Finally, 21 studies containing 23, 848 blood samples were included in the final analysis. The basic characteristics and data extraction from these included studies was shown in **[Table 1](#pone.0175592.t001){ref-type="table"}**.

![Flow chart of studies selection process in this meta-analysis.](pone.0175592.g001){#pone.0175592.g001}

10.1371/journal.pone.0175592.t001

###### Basic characteristics of the included studies in this meta-analysis.

![](pone.0175592.t001){#pone.0175592.t001g}

  First author (ref.)                Publication year   Province   Sampling time     Sampling method        Region          Sample size   No. of positive   P\* (%)   No. of research spot   Quality Score   Endemic   Language   Test method
  ---------------------------------- ------------------ ---------- ----------------- ---------------------- --------------- ------------- ----------------- --------- ---------------------- --------------- --------- ---------- -------------
  Wei \[[@pone.0175592.ref022]\]     2015               SX         2014              NA                     Rural           363           20                5.51      1 village              6               Y         ENG        D-ELISA
  Hu \[[@pone.0175592.ref023]\]      2015               HN         2011.7--2013.12   Physical examination   Urban & rural   5245          343               6.54      213 towns              7               Mixed     ENG        ELISA
  Zhan \[[@pone.0175592.ref024]\]    2013               HB         2010--2012        NA                     Urban & rural   957           61                6.37      9 towns                6               Mixed     CHN        ELISA
  Xing \[[@pone.0175592.ref025]\]    2015               HB         2012.8--2013.5    NA                     Rural           419           35                8.35      7 villages             6               Y         ENG        D-ELISA
  Wang \[[@pone.0175592.ref026]\]    2016               ZJ         2015.10--12       Randomly               Rural           200           15                7.50      2 villages             6               Mixed     CHN        ELISA
  Zhang \[[@pone.0175592.ref027]\]   2014               ZJ         2013              NA                     Rural           120           11                9.17      3 villages             6               Y         ENG        D-ELISA
  Sun \[[@pone.0175592.ref028]\]     2015               ZJ         2013              Randomly               Rural           1380          76                5.51      6 districts            8               Y         ENG        ELISA
  Tan \[[@pone.0175592.ref029]\]     2015               JS         2010\~2011        NA                     Rural           866           2                 0.23      5 towns                6               Mixed     CHN        D-ELISA
  Liang \[[@pone.0175592.ref030]\]   2014               JS         2011              NA                     Urban & rural   2510          10                0.44      7 counties             7               Mixed     ENG        D-ELISA
  Li \[[@pone.0175592.ref031]\]      2014               JS         2012.3--2013.1    Randomly               Rural           2547          33                1.30      6 counties             8               Y         ENG        D-ELISA
  Zhang \[[@pone.0175592.ref032]\]   2011               JS         2010.7--11        NA                     Rural           1922          17                0.94      6 districts            6               Y         CHN        D-ELISA
  Jiao \[[@pone.0175592.ref033]\]    2011               JS&AH      2010              NA                     Rural           250           9                 3.60      2 districts            5               Y         ENG        D-ELISA
  Huang \[[@pone.0175592.ref034]\]   2016               AH         2012.6            Randomly               Rural           270           17                6.30      8 towns                8               N         ENG        ELISA
  Xu \[[@pone.0175592.ref035]\]      2015               AH         2013.9--10        Randomly               Rural           166           14                8.43      8 villages             6               Mixed     CHN        ELISA
  Lyu \[[@pone.0175592.ref036]\]     2016               AH         2014--2015        NA                     Rural           2126          99                4.66      12 villages            7               Y         ENG        ELISA
  Niu \[[@pone.0175592.ref037]\]     2013               SD         2011              NA                     Rural           2590          140               5.41      30 villages            8               Y         CHN        I-ELISA
  Wang \[[@pone.0175592.ref038]\]    2013               SD         2010--2011        NA                     Rural           315           4                 1.27      1 county               6               Y         CHN        D-ELISA
  Zhou \[[@pone.0175592.ref039]\]    2014               SD         2011\. 4--12      Randomly               Rural           1525          138               9.05      NA                     6               Y         CHN        I-ELISA
  Luo \[[@pone.0175592.ref040]\]     2016               SD         2015.11--2016.1   Randomly               Rural           628           33                5.25      9 villages             8               Y         CHN        ELISA
  Zhao \[[@pone.0175592.ref041]\]    2012               SD         2011.6            Convenience            Rural           237           2                 0.84      2 villages             7               Y         ENG        D-ELISA
  Cui \[[@pone.0175592.ref042]\]     2013               SD         2011              NA                     Rural           78            1                 1.30      5 villages             6               Y         ENG        D-ELISA

*Abbreviations*: SX, Shaanxi province; ZJ, Zhejiang province; JS, Jiangsu province; SD, Shandong province; AH, Anhui province; HN, Henan province; HB, Hubei province; ENG, English; CHN, Chinese; NA, not available.

P\*(%), positive rate for SFTSV-specific IgG or IgM by using a double-antigen sandwich enzyme-linked immunosorbent assay (D-ELISA) or indirect-ELISA.

Characteristics of included studies {#sec014}
-----------------------------------

For these 21 articles, sample sizes across the studies ranged from 78 to 2590. 12 of the studies were published in English and 9 in Chinese. 6 studies were of high quality, other studies were of moderate quality (**[Table 1](#pone.0175592.t001){ref-type="table"}**). Generally, the most prevalence studies were conducted in the center and east of China (Shaanxi \[[@pone.0175592.ref022]\], Henan \[[@pone.0175592.ref023]\], Hubei \[[@pone.0175592.ref024], [@pone.0175592.ref025]\], Zhejiang \[[@pone.0175592.ref026]--[@pone.0175592.ref028]\], Jiangsu \[[@pone.0175592.ref029]--[@pone.0175592.ref032]\], Jiangsu&Anhui \[[@pone.0175592.ref033]\], Anhui \[[@pone.0175592.ref034]--[@pone.0175592.ref036]\], and Shandong provinces \[[@pone.0175592.ref037]--[@pone.0175592.ref042]\]), the location of referred provinces in China was shown in **[Fig 2](#pone.0175592.g002){ref-type="fig"}**.

![Location of referred provinces in China where serum samples of healthy persons were collected and tested for the presence of severe fever with thrombocytopenia syndrome virus--specific IgG and IgM.](pone.0175592.g002){#pone.0175592.g002}

Overall seroprevalence of SFTSV {#sec015}
-------------------------------

Seroprevalence of SFTSV antibodies varied from 0.23% to 9.17% and were displayed as forest plots in **[Fig 3](#pone.0175592.g003){ref-type="fig"}**. The heterogeneity across the studies was high (Q = 774.93, *P*\<0.001; *I*^*2*^ = 97.3%). The overall pooled seroprevalence estimate for SFTSV in random effect model was 4.3% (95%CI: 3.2%-5.5%).

![Forest plot of seroprevalence for total antibodies against SFTSV in healthy population.\
The middle point of each line indicates the prevalence rate and the length of line indicates 95% confidence interval of each study. Rhombus shape indicates 95% confidence interval for all studies.](pone.0175592.g003){#pone.0175592.g003}

Subgroup analysis {#sec016}
-----------------

To explore the potential source of the high heterogeneity, we did some subgroup analysis by gender, age, occupation and province. The detail results of subgroup analysis were shown in **[Table 2](#pone.0175592.t002){ref-type="table"}**. Stratification by gender, the pooled prevalence of male was 5.3% (95%CI: 3.3%-7.2%), and female was 5.2% (95%CI: 3.4%-7.0%). Stratification by age, the pooled seroprevalence of less than age of 40 years was 4.1% (95%CI: 2.4%-5.7%), and more than age of 40 years was 4.9% (95%CI: 2.9%-7.0%). Stratification by occupation, the pooled seroprevalence of farmer was 6.1% (95%CI: 3.4%-8.9%) and others (mainly are students) was 3.3% (95%CI: 2.4%-4.2%). Seropositive rates were comparable among sampling years, seroprevalence in the years before 2012 and after 2012 was 3.1% (1.9%-4.4%) and 5.2% (4.6%-5.9%), respectively. Stratification by testing method, seroprevalence in the method of I-ELISA and D-ELISA was 6.2% (5.4%\~7.1%) and 1.8% (1.1%\~2.5%), respectively. Seroprevalence of SFTSV in people who lived in the same village with the patient and lived in a different village was 6.5% (4.7\~8.3) and 4.1% (3.1%\~5.1%), respectively. We also found seroprevalence in endemic area was 4.3% (3.1%\~5.6%) and in rural village was 4.3% (3.2%\~5.4%). Additionally, the pooled seroprevalence was 5.9% (95%CI: 4.7%-7.0%) in Zhejiang province, 3.9% (95%CI: 1.3%-6.4%) in Shandong province, 4.9% (95%CI: 4.1--5.8%) in Anhui province, 6.9% (5.5%\~8.2%) in Hubei province and 0.7% (95%CI: 0.2%-1.1%) in Jiangsu province. Forest plots for the meta-analysis in different provinces were shown in **[Fig 4](#pone.0175592.g004){ref-type="fig"}**.

![Forest plots of seroprevalence for total antibodies against SFTSV in healthy population among different provinces.](pone.0175592.g004){#pone.0175592.g004}

10.1371/journal.pone.0175592.t002

###### The seroprevalence of total antibodies (IgG/IgM) against SFTSV in different subgroups of humans in China.

![](pone.0175592.t002){#pone.0175592.t002g}

  Characters             No. studies   P ^a^ (%)   *95%CI* for P ^a^   Heterogeneity   Model   
  ---------------------- ------------- ----------- ------------------- --------------- ------- ---
  Gender                                                                                       
      Male               11            5.3         3.3\~7.2            \<0.001         96.4    R
      Female             11            5.2         3.4\~7.0            \<0.001         97.1    R
  Age, years                                                                                   
      \<40               9             4.1         2.4\~5.7            \<0.001         96.0    R
      ≥40                10            4.9         2.9\~7.0            \<0.001         97.6    R
  Occupation                                                                                   
      Farmer             7             6.1         3.4\~8.9            \<0.001         96.7    R
      Others\*           6             3.3         2.4\~4.2            0.301           17.9    F
  Province                                                                                     
      Zhejiang           3             5.9         4.7\~7.0            0.256           26.5    F
      Shandong           6             3.9         1.3\~6.4            0.001           95.5    R
      Jiangsu            4             0.7         0.2\~1.1            0.001           81.6    R
      Anhui              3             4.9         4.1\~5.8            0.147           47.9    F
      Hubei              2             6.9         5.5\~8.2            0.206           37.5    F
  Quality                                                                                      
      High               5             4.7         2.2\~7.1            \<0.001         96.4    R
      Moderate           15            3.8         2.4\~5.2            \<0.001         97.6    R
  Area                                                                                         
      Endemic            14            4.2         2.8\~5.5            \<0.001         95.7    R
  Population                                                                                   
      Rural              17            4.2         3.0\~5.3            \<0.001         96.3    R
      Case villages      10            6.5         4.7\~8.3            \<0.001         89.5    R
      Control villages   3             4.1         3.1\~5.1            0.178           38.9    F
  Sampling time                                                                                
      ≤2012              11            3.1         1.9\~4.4            \<0.001         96.8    R
      \>2012             7             5.2         4.6\~5.9            0.257           22.6    F
  Testing method                                                                               
      I-ELISA            10            6.2         5.4\~7.1            \<0.001         73.3    R
      D-ELISA            11            1.8         1.1\~2.5            \<0.001         88.2    R
  Total                  21            4.3         3.2\~5.5            \<0.001         97.3    R

*Abbreviations*: F, fixed model; R, random model.

P^a^. The seroprevalence of total antibodies (IgG/IgM) against SFTSV.

P^b^. P value of Q-test for heterogeneity test. When the P value was less than 0.10, the random effects model was used to assess the summary seroprevalence.

Others\*: Students are the main portion.

Publication bias and sensitive analysis {#sec017}
---------------------------------------

Potential publication bias of the included articles were evaluated by Begg's funnel plots and Egger's test. The shapes of the funnel plot was asymmetry evidently which gives rise to suspected publication bias (**[Fig 5](#pone.0175592.g005){ref-type="fig"}**). The Egger's test results demonstrated evidence of publication bias, however, the Begg's bias test was not significant for studies reporting seroprevalence of SFTSV (data not shown). A leave-one-out analysis which was performed to assess the impact of the individual study on the pooled estimates. Sensitive analysis showed that no single study qualitatively altered the pooled seroprevalence estimates, providing evidence of the stability of the meta-analysis (**[Fig 6](#pone.0175592.g006){ref-type="fig"}**).

![Funnel plot assessing publication bias in studies reporting SFTSV seroprevalence.](pone.0175592.g005){#pone.0175592.g005}

![Sensitivity analysis of the summary seroprevalence of SFTSV.\
Results were computed by omitting each study in turn under random-effects model.](pone.0175592.g006){#pone.0175592.g006}

Discussion {#sec018}
==========

SFTS as a global concerned infectious disease has posed a great threat on human health in East Asia. China is one of the most important endemic areas, more than 5000 cases of SFTS were reported in China from 2011 to 2014 \[[@pone.0175592.ref043]\].

This systematic review and meta-analysis was performed to evaluate the seroprevalence of SFTSV in Chinese population. Twenty one articles compromising a total of 23,848 individuals were included for analysis. Published seroprevalence ranged from 0.23% to 9.17%. We found that, among healthy population in China, the overall pooled seroprevalence of SFTSV was 4.3% (95%CI: 3.2%-5.4%). It was higher than a recent investigation in Korean population with a seroprevalence of 2.1% based on 1069 serum samples \[[@pone.0175592.ref044]\]. Sensitivity analysis by omitting one study at a time did not have substantial impact on the result, indicating the pooled result of seroprevalence was robust. Considerable heterogeneity was found among studies that can be at least partly explained by occupation, the geographical location and the anti-SFTSV antibodies assay employed.

Previous study reported gender ratio of SFTS patients in China was about 1:1.15 (male/female), but it varied among different provinces \[[@pone.0175592.ref045]\]. In this study, we found the seroprevalence of SFTSV in male was approximate with that in female. In addition, epidemiologic investigations showed that the majority of SFTS patients included retired or unemployed citizens and farmers. \[[@pone.0175592.ref046], [@pone.0175592.ref047]\]. Stratified by occupation in this meta-analysis, we found the seroprevalence of SFTSV in farmer was higher than other occupation (mainly are students), which indicates that farmers are the high risk population to SFTSV infections. It is believed that farmers take the main agriculture activities such as grass mowing, raising cattle, grazing in the bushes where ticks is highly intensive and active \[[@pone.0175592.ref022]\]. This high exposure experience could prominently increase the risk to SFTSV infection. Appropriate protective measures for farmers to repel ticks should be took when working outdoors.

Age composition of SFTS patients was widely, previous studies had demonstrated that SFTS patients ranged from 1 to 93 years old, but most of patients were aggregated in 40--79 years \[[@pone.0175592.ref041]\]. Generally, age was considered as a critical risk factor for morbidity and mortality of SFTS \[[@pone.0175592.ref041]\]. However, the results of seroprevalence in healthy people among different age groups were controversial. Some studies reported an increasing trend with age about the seroprevalence of SFTSV in healthy population \[[@pone.0175592.ref022], [@pone.0175592.ref023], [@pone.0175592.ref028], [@pone.0175592.ref031], [@pone.0175592.ref034]\], while other studies failed to find any significant difference among different age groups \[[@pone.0175592.ref030], [@pone.0175592.ref033], [@pone.0175592.ref041]--[@pone.0175592.ref043]\]. In this meta-analysis, the pooled data indicated the seroprevalence of SFTSV in people over 40 years old was close to people who less than 40 years old. This result indicated that all age groups were susceptible to SFTSV infection, but only aged people is inclined to get severe disease and to be hospitalized or even died of SFTSV infection.

The infections rates of healthy population varied in different provinces. It reflects that incidences of the latent infection of SFTS are different in endemic regions. In this study, we found SFTSV seroprevalence was high in Henan, Hubei, Zhejiang, Shanxi, Anhui and Shandong provinces, and was relatively low in Jiangsu provinces with seroprevalence of 0.7% (95%CI: 0.2\~1.1). However, this result should be interpreted with cautious because of limiting number of study and sample size in some provinces, which may lead to lack of representativeness.

Additionally, different ELISA assay such as indirect ELISA (I-ELISA) and double-antigen sandwich ELISA system (D-ELISA) used to detect SFTSV-specific antibodies might also contribute to heterogeneity. Compared to the traditional I-ELISA, D-ELISA was considered having more higher sensitivity to detect total antibodies \[[@pone.0175592.ref033]\]. However, in the present meta-analysis, seroprevalence in the group of I-ELISA method was higher than that in the D-ELISA group. A potential explanation is that D-ELISA method was mainly used in Jiangsu province, where seroprevalence of SFTSV is relatively lower than other provinces.

Seroprevalence was also observed between different years, seroprevalence in the year after 2012 was higher than that before 2012, indicating ongoing and intensified circulation of SFTSV in endemic areas of China. Another discrepancy may be attributed to the sampling season, sampling method, previous contacting with animals (such as raising domestic animals, especially goats), or antibody types (total antibodies or IgG/ IgM antibody) detection in different studies.

The advantage of this systematic review and meta-analysis is that good quality studies from many centers were pooled for a relatively large sample size, but there are several limitations also should be addressed. Firstly, significant heterogeneity was detected across studies. Although we did some subgroup analysis to identify sources of heterogeneity, many unmeasured factors may have influenced the results. Secondly, funnel plots and Begg's tests indicated that publication bias might be exist in the present study, which may distort the estimates of seroprevalence, so that the results should be interpreted with cautions.

In summary, data from 21 published studies suggested that SFTS is circulated widely in China and could be a cause of considerable health problems in the country. Surveillance efforts on mild or asymptomatic infections among endemic persons are needed. Further subtle-designed studies are still needed to describe the exact epidemiology of the disease at a national level in other parts of China.
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